The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Recommendations on the Use of 18F-FDG PET in Oncology
Open accessAbstract
UNLABELLED: The rationale was to develop recommendations on the use of (18)F-FDG PET in breast, colorectal, esophageal, head and neck, lung, pancreatic, and thyroid cancer; lymphoma, melanoma, and sarcoma; and unknown primary tumor. Outcomes of interest included the use of (18)F-FDG PET for diagnosing, staging, and detecting the recurrence or progression of cancer. METHODS: A search was performed to identify all published randomized controlled trials and systematic reviews in the literature. An additional search was performed to identify relevant unpublished systematic reviews. These publications comprised both retrospective and prospective studies of varied methodologic quality. The anticipated consequences of false-positive and false-negative tests when evaluating clinical usefulness, and the impact of (18)F-FDG PET on the management of cancer patients, were also reviewed. RESULTS AND CONCLUSION: (18)F-FDG PET should be used as an imaging tool additional to conventional radiologic methods such as CT or MRI; any positive finding that could lead to a clinically significant change in patient management should be confirmed by subsequent histopathologic examination because of the risk of false-positive results. (18)F-FDG PET should be used in the appropriate clinical setting for the diagnosis of head and neck, lung, or pancreatic cancer and for unknown primary tumor. PET is also indicated for staging of breast, colon, esophageal, head and neck, and lung cancer and of lymphoma and melanoma. In addition, (18)F-FDG PET should be used to detect recurrence of breast, colorectal, head and neck, or thyroid cancer and of lymphoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · BMJ · doi:10.1136/bmj.326.7379.41 · Cited by 3,215
Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Lijmer, J. G., Moher, D., Rennie, D., & de Vet, H. C. W. (2003) · Radiology · doi:10.1148/radiol.2261021292 · Cited by 3,215
�ber den Stoffwechsel der Carcinomzelle
Warburg, O. (1924) · Die Naturwissenschaften · doi:10.1007/bf01504608 · Cited by 631
Cited by
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Boellaard, R., Delgado-Bolton, R., Oyen, W. J. G., Giammarile, F., Tatsch, K., Eschner, W., Verzijlbergen, F. J., Barrington, S. F., Pike, L. C., Weber, W. A., et al. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2961-x · Cited by 3,303
Self-citationLactate Metabolism in Human Lung Tumors
Faubert, B., Li, K. Y., Cai, L., Hensley, C. T., Kim, J., Zacharias, L. G., Yang, C., Do, Q. N., Doucette, S., Burguete, D., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.019 · Cited by 1,343
Metabolic heterogeneity in human lung tumors
Hensley, C. T., Faubert, B., Yuan, Q., Lev-Cohain, N., Jin, E., Kim, J., Jiang, L., Ko, B., Skelton, R., Loudat, L., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.034 · Cited by 1,138
Imaging biomarker roadmap for cancer studies
O'Connor, J. P. B., Aboagye, E. O., Adams, J. E., Aerts, H. J. W. L., Barrington, S. F., Beer, A. J., Boellaard, R., Bohndiek, S. E., Brady, M., Brown, G., et al. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.162 · Cited by 1,091
Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome
O'Connor, J. P. B., Rose, C. J., Waterton, J. C., Carano, R. A. D., Parker, G. J. M., & Jackson, A. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0990 · Cited by 677
Kinahan, P. E., & Fletcher, J. W. (2010) · Seminars in Ultrasound, CT and MRI · doi:10.1053/j.sult.2010.10.001 · Cited by 631
Self-citationSlow TCA flux and ATP production in primary solid tumours but not metastases
Bartman, C. R., Weilandt, D. R., Shen, Y., Lee, W. D., Han, Y., TeSlaa, T., Jankowski, C. S. R., Samarah, L., Park, N. R., da Silva-Diz, V., et al. (2023) · Nature · doi:10.1038/s41586-022-05661-6 · Cited by 299
HIF-1 in cancer therapy: two decade long story of a transcription factor
Soni, S., & Padwad, Y. S. (2017) · Acta Oncologica · doi:10.1080/0284186x.2017.1301680 · Cited by 251
“This is such a reliable indication that it acts as a basis for diagnosis of tumor in patients by 18-F-fluorodeoxyglucose-positron emission tomography (FDG-PET) to ascertain metastases by imaging of FDG tracer [63].”
BackgroundThe Diverse Functions of Non-Essential Amino Acids in Cancer
Choi, B.-H., & Coloff, J. L. (2019) · Cancers · doi:10.3390/cancers11050675 · Cited by 213
Akamatsu, G., Ishikawa, K., Mitsumoto, K., Taniguchi, T., Ohya, N., Baba, S., Abe, K., & Sasaki, M. (2012) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.103861 · Cited by 206
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems
Kaalep, A., Sera, T., Oyen, W., Krause, B. J., Chiti, A., Liu, Y., & Boellaard, R. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3853-7 · Cited by 174
Feasibility of state of the art PET/CT systems performance harmonisation
Kaalep, A., Sera, T., Rijnsdorp, S., Yaqub, M., Talsma, A., Lodge, M. A., & Boellaard, R. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-3977-4 · Cited by 160
Fonti, R., Conson, M., & Del Vecchio, S. (2019) · Seminars in Oncology · doi:10.1053/j.seminoncol.2019.07.001 · Cited by 153
Zhao, X., Li, L., Zhao, Y., An, H., Cai, Q., Lang, J., Han, X., Peng, B., Fei, Y., Liu, H., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201908185 · Cited by 147
Akamatsu, G., Mitsumoto, K., Taniguchi, T., Tsutsui, Y., Baba, S., & Sasaki, M. (2014) · European Journal of Radiology · doi:10.1016/j.ejrad.2013.09.030 · Cited by 96
Quantitative implications of the updated EARL 2019 PET–CT performance standards
Kaalep, A., Burggraaff, C. N., Pieplenbosch, S., Verwer, E. E., Sera, T., Zijlstra, J., Hoekstra, O. S., Oprea-Lager, D. E., & Boellaard, R. (2019) · EJNMMI Physics · doi:10.1186/s40658-019-0257-8 · Cited by 79
Howard, B. A., Morgan, R., Thorpe, M. P., Turkington, T. G., Oldan, J., James, O. G., & Borges-Neto, S. (2017) · Annals of Nuclear Medicine · doi:10.1007/s12149-017-1192-1 · Cited by 70
Effects of blood glucose level on FDG uptake by liver: a FDG-PET/CT study
Kubota, K., Watanabe, H., Murata, Y., Yukihiro, M., Ito, K., Morooka, M., Minamimoto, R., Hori, A., & Shibuya, H. (2011) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2010.09.004 · Cited by 66
Grootjans, W., de Geus-Oei, L.-F., Meeuwis, A. P. W., van der Vos, C. S., Gotthardt, M., Oyen, W. J. G., & Visser, E. P. (2014) · European Radiology · doi:10.1007/s00330-014-3362-z · Cited by 57
Li, C.-Y., Klohr, S., Sadick, H., Weiss, C., Hoermann, K., Schoenberg, S. O., & Sadick, M. (2014) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.114.141192 · Cited by 15
Two-Time-Point FDG PET/CT: Liver SULmean Repeatability
Tahari, A. K., Paidpally, V., Chirindel, A., Wahl, R. L., & Subramaniam, R. M. (2015) · American Journal of Roentgenology · doi:10.2214/ajr.14.12719 · Cited by 10
Self-citationRelationship between sex hormones levels and 18 F-FDG uptake by the ovaries in premenopausal woman
Kim, T. H., Kim, M. R., Jung, Y., & An, Y.-S. (2019) · Radiology and Oncology · doi:10.2478/raon-2019-0035 · Cited by 8
Metadata
- Authors
- Fletcher, J. W., Djulbegovic, B., Soares, H. P., Siegel, B. A., Lowe, V. J., Lyman, G. H., Coleman, R. E., Wahl, R., Paschold, J. C., Avril, N., Einhorn, L. H., Suh, W. W., Samson, D., Delbeke, D., Gorman, M., & Shields, A. F.
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2008-02-20
- Volume
- 49
- Issue
- 3
- Pages
- 480-508
- ISSN
- 0161-5505 (ISSN-L)
- 2159-662X
- OpenAlex
- W2096719319
- Cited by
- 1,101
- References
- 4
- FWCI
- 57.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
